ARCHIVES

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

This article is from The Cancer Letter archive.

Vol. 02 No. 40 | October 1, 1976

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

NIH To Replace RAC With New Committee

July 19, 1996

Supreme Court Upholds Affordable Care Act in 5-4 Decision, Narrows Medicaid Provision

June 29, 2012

Avoiding the Hippocampus During Whole-Brain Radiotherapy Can Preserve Memory Function

September 27, 2013

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009